Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results

July 8, 2020

ArcherDX drops IPO plans in favor of a $1.4B takeover by Invitae

July 8, 2020

Millendo Therapeutics Provides Corporate and Pipeline Update

July 8, 2020

ArcherDX and Invitae to Create a Global Leader in Comprehensive Cancer Genetics and Precision Oncology

July 8, 2020

ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research

June 19, 2020

Lassen Therapeutics Emerges from Stealth with $31M to Target IL-11 in Cancer, Fibrosis

June 18, 2020
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved